🏆 TechInvention recognized in Forbes India Select 200, featured among companies with Global Business Potential, reflecting the company's rapid growth and industry leadership.
Brand Logo

Innovative Products for Global Health

Discover our extensive range of high-quality vaccines designed to make healthcare accessible, reliable, and affordable worldwide.

Advanced Biotech Manufacturing and Formulation Facility

Product Details

1

Product Name: TdaPgen

Combined Tetanus Toxoid, Reduced Diphtheria Toxoid and Reduced Recombinant Pertussis Vaccine

Label Composition
  • Each single dose of 0.5 mL contains:
  • • Tetanus Toxoid — 7.5 Lf
  • • Diphtheria Toxoid — 2.0 Lf
  • • Bordetella pertussis antigens:
  • • Recombinant Pertussis Toxin (rPT) — 2 µg
  • • Filamentous Haemagglutinin (FHA) — 5 µg
Pack
0.5 mL Prefilled Syringe
Therapeutic Use
Active booster immunization against diphtheria, tetanus and pertussis in individuals aged 4 to 65 years.
2

Product Name: Varicella Vaccine, Live Attenuated

Label Composition
  • Each single dose of 0.5 mL contains:
  • • Live Attenuated Varicella-Herpes Zoster Virus (Oka strain) — 3.3 to 4.5 lg PFU/0.5 mL per dose
  • • Produced in human diploid (SV-1) cells
  • • International standard virus strain purchased from ATCC
  • • Virus titer tested using an in-house reference
Pack
Vial and WFI
Therapeutic Use
Active immunization against infection caused by varicella in individuals aged 1 year (12 months) to 12 years.
3

Product Name: Inactivated Hepatitis A Vaccine (Adsorbed) I.P.

Label Composition
  • Each single dose of 0.5 mL contains:
  • • Inactivated HAV antigen (TZ84 strain)¹ — 250 U
  • • Aluminium, as Aluminium Hydroxide — 0.175 to 0.31 mg
  • • Disodium Hydrogen Phosphate — q.s.
  • • Sodium Chloride — 4.5 mg
  • • Sodium Dihydrogen Phosphate — q.s.
  • • Water for Injection — q.s. to 0.5 mL
  • • ¹ Produced in Human Diploid Cells
Pack
Vial / Prefilled Syringe
Therapeutic Use
Active immunization against infection caused by Hepatitis A virus.
4

Product Name: Trivalent Influenza Vaccine

Label Composition
  • Each single dose of 0.5 mL contains:
  • • Each 0.5 mL dose contains 15 µg haemagglutinin (HA) of each influenza virus strain selected in accordance with the annual recommendations of the World Health Organization (WHO) for the applicable Northern or Southern Hemisphere influenza season.
Pack
Prefilled Syringe
Therapeutic Use
Active immunization of adults aged 18 years and older for prevention of influenza disease.

Access-Oriented

Built to support availability of essential vaccines across priority markets.

Market-Ready

Focused on regulated, market-authorized vaccine candidates.

Partnership-Led

Designed for institutional, commercial and public health collaborations.

Adverse Event Reporting

For any questions or to report an Adverse Event, please contact our AE Reporting team:

Phone: 18008902590
Email: feedback@techinvention.biz
Download Reporting Form: AE Reporting form and send your response to the aforementioned email.

Your privacy is important to us.

All AE reports shall be handled with strict confidentiality.

Personal information is protected and used solely for safety monitoring purposes.

Partner With TechInvention for Vaccine Access

Connect with TechInvention to explore product availability, licensing partnerships and access opportunities for market-authorized vaccines.

Connect Now
+91 22 4005 2123connect@techinvention.biz